Lung Cancer Drugs

Get an ideas about the lung cancer treatment drugs, here we provide only information about drugs not to advice them to take without proper doctor guideline. For information about lung cancer drugs browse.

FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation

Lumakras (sotorasib)
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific [...]

Topotecan–Berzosertib Combination Effective for SCLC Treatment

Skeletal Model of Topotecan
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of [...]

FDA Approves Libtayo as Monotherapy for Advanced NSCLC

Libtayo | Lung Cancer
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]

New Study Identifies Drug to Boost Lung Cancer Survival Rates

Lung Cancer
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]

Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk

Drug
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]

NICE now recommends AstraZeneca’s Tagrisso for Lung Cancer Treatment

lung | Lung Cancer
The National Institute of Health and Care Excellence (NICE) has announced the recommendation of Tagrisso (osimertinib) for routine use in two new lung cancer [...]

FDA Approves Gavreto for Metastatic Non-Small Cell Lung Cancer

FDA Approved | Lung Cancer
The Food and Drug Administration (FDA) has approved Gavreto (pralsetinib) for treatment of patients with metastatic non-small cell lung cancer (NSCLC). [...]

Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]

U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer

Lung Cancer Therapy
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new [...]

FDA Approves Tabrecta, First Targeted Therapy for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]

Nintedanib for Treatment of Advanced Lung Cancer

Nintedanib | Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. [...]

Pairing Lung and Breast Cancer Drugs More Effective in Killing Cancer Cells

Drugs | Lung Cancer
According to the new study, if the drugs used to treat breast and lung cancer are combined, they overcome resistance to treatment. The study is published in [...]

Vizimpro Recommended on NHS for Non-Small Cell Lung Cancer

lung | Lung Cancer
Health officials have approved life-extending pill for patients with an aggressive form of lung cancer. Vizimpro has been recommended as a first-line treatment [...]

Tecentriq Plus Chemotherapy Approved for Small Cell Lung Cancer

Tecentriq Plus Chemotherapy Approved for Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Tecentriq, in combination with carboplatin and etoposide for the first-line treatment of patients suffering [...]

Drug: Tagrisso (Osimertinib) to Treat NSCLC

Tagrisso-(Osimertinib) | Lung Cancer
Osimertinib or Tagrisso is an FDA-approved drug by FDA as a frontline treatment for patients with non-small cell lung cancer (NSCLC). It is indicated for the [...]

Research: Scientists Discover New Drug Target for Lung Cancer

Doctor
A group of researchers at the University of Cambridge have identified lung squamous cell carcinoma (LUSC) cells containing high amounts of protein called [...]